These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38590132)

  • 1. Proteomic Identification of Small Extracellular Vesicle Proteins LAMB1 and Histone H4 for Prostate Cancer Diagnosis and Risk Stratification.
    Pang B; Wang Q; Chen H; Liu Z; Han M; Gong J; Yue L; Ding X; Wang S; Yan Z; Chen Y; Malouf D; Bucci J; Guo T; Zhou C; Jiang J; Li Y
    Adv Sci (Weinh); 2024 Jun; 11(23):e2402509. PubMed ID: 38590132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
    Sequeiros T; Rigau M; Chiva C; Montes M; Garcia-Grau I; Garcia M; Diaz S; Celma A; Bijnsdorp I; Campos A; Di Mauro P; Borrós S; Reventós J; Doll A; Paciucci R; Pegtel M; de Torres I; Sabidó E; Morote J; Olivan M
    Oncotarget; 2017 Jan; 8(3):4960-4976. PubMed ID: 27903962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Extracellular Vesicle Isolation Methods on Downstream Mirna Analysis in Semen: A Comparative Study.
    Mercadal M; Herrero C; López-Rodrigo O; Castells M; de la Fuente A; Vigués F; Bassas L; Larriba S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32824915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
    Fujita K; Kume H; Matsuzaki K; Kawashima A; Ujike T; Nagahara A; Uemura M; Miyagawa Y; Tomonaga T; Nonomura N
    Sci Rep; 2017 Feb; 7():42961. PubMed ID: 28211531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Vesicle Proteome in Prostate Cancer: A Comparative Analysis of Mass Spectrometry Studies.
    Bernardino RMM; Leão R; Henrique R; Pinheiro LC; Kumar P; Suravajhala P; Beck HC; Carvalho AS; Matthiesen R
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential tissue expression of extracellular vesicle-derived proteins in prostate cancer.
    Duijvesz D; Rodriguez-Blanco G; Hoogland AM; Verhoef EI; Dekker LJ; Roobol MJ; van Leenders GJLH; Luider TM; Jenster G
    Prostate; 2019 Jun; 79(9):1032-1042. PubMed ID: 31018022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative urinary proteomics using stable isotope labelling by peptide dimethylation in patients with prostate cancer.
    Li C; Zang T; Wrobel K; Huang JT; Nabi G
    Anal Bioanal Chem; 2015 May; 407(12):3393-404. PubMed ID: 25724369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profile.
    Vermassen T; D'Herde K; Jacobus D; Van Praet C; Poelaert F; Lumen N; Callewaert N; Decaestecker K; Villeirs G; Hoebeke P; Van Belle S; Rottey S; Delanghe J
    J Clin Pathol; 2017 Oct; 70(10):838-846. PubMed ID: 28360190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis.
    Pang B; Zhu Y; Ni J; Thompson J; Malouf D; Bucci J; Graham P; Li Y
    Theranostics; 2020; 10(5):2309-2326. PubMed ID: 32089744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplexed quantitative proteomics in prostate cancer biomarker development.
    Gao Y; Kim H; Kitata RB; Lin TT; Swensen AC; Shi T; Liu T
    Adv Cancer Res; 2024; 161():31-69. PubMed ID: 39032952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
    Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
    PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer-derived small extracellular vesicle proteins: the hope in diagnosis, prognosis, and therapeutics.
    Chen H; Pang B; Zhou C; Han M; Gong J; Li Y; Jiang J
    J Nanobiotechnology; 2023 Dec; 21(1):480. PubMed ID: 38093355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer-derived extracellular vesicles metabolic biomarkers: Emerging roles for diagnosis and prognosis.
    Hamed MA; Wasinger V; Wang Q; Graham P; Malouf D; Bucci J; Li Y
    J Control Release; 2024 Jul; 371():126-145. PubMed ID: 38768661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkers.
    Tomiyama E; Matsuzaki K; Fujita K; Shiromizu T; Narumi R; Jingushi K; Koh Y; Matsushita M; Nakano K; Hayashi Y; Wang C; Ishizuya Y; Kato T; Hatano K; Kawashima A; Ujike T; Uemura M; Takao T; Adachi J; Tomonaga T; Nonomura N
    Cancer Sci; 2021 May; 112(5):2033-2045. PubMed ID: 33721374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic profiling in tissues and urine of patients with prostatic lesions and the diagnostic value of urine extracellular vesicles metabolites in prostate cancer.
    Ding T; He W; Yan H; Wei Z; Zeng X; Hao X
    Clin Chim Acta; 2024 Mar; 556():117845. PubMed ID: 38403146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semen sEV tRF-Based Models Increase Non-Invasive Prediction Accuracy of Clinically Significant Prostate Cancer among Patients with Moderately Altered PSA Levels.
    Ferre-Giraldo A; Castells M; Sánchez-Herrero JF; López-Rodrigo O; de Rocco-Ponce M; Bassas L; Vigués F; Sumoy L; Larriba S
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate extracellular vesicles in patient plasma as a liquid biopsy platform for prostate cancer using nanoscale flow cytometry.
    Biggs CN; Siddiqui KM; Al-Zahrani AA; Pardhan S; Brett SI; Guo QQ; Yang J; Wolf P; Power NE; Durfee PN; MacMillan CD; Townson JL; Brinker JC; Fleshner NE; Izawa JI; Chambers AF; Chin JL; Leong HS
    Oncotarget; 2016 Feb; 7(8):8839-49. PubMed ID: 26814433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
    Tomlins SA; Day JR; Lonigro RJ; Hovelson DH; Siddiqui J; Kunju LP; Dunn RL; Meyer S; Hodge P; Groskopf J; Wei JT; Chinnaiyan AM
    Eur Urol; 2016 Jul; 70(1):45-53. PubMed ID: 25985884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics in diagnosis of prostate cancer.
    Davalieva K; Polenakovic M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.
    Duijvesz D; Burnum-Johnson KE; Gritsenko MA; Hoogland AM; Vredenbregt-van den Berg MS; Willemsen R; Luider T; Paša-Tolić L; Jenster G
    PLoS One; 2013; 8(12):e82589. PubMed ID: 24391718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.